Save Time, Improve Quality | Saama - #1 in AI Clinical Analytics
A top-10 pharmaceutical company wanted to speed up transforming raw clinical data into CDISC SDTM standard format for regulatory submissions without sacrificing quality, to reduce mapping timelines and speed time-to-market across its portfolio. It implemented Saama's Source to Submission (S2S) solution for SDTM data transformation. Stated results: a 25% time savings in data-mapping activities per study, 70% auto-mapping accuracy out of the box using Saama's AI models, and SDTM data transformations completed in 3 weeks.
The customer is anonymised in Saama’s own case study — not withheld by us.
Saama is an AI platform for clinical data management — automated data-query generation, data-quality scoring and raw-to-SDTM transformation used during live trial conduct.
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Saama on its own site — read the original case study on saama.com ↗
Related use cases
- 01Agentic Transformation: From Fragmented Systems to Integrated Care Intelligence
- 02More Data, More Insights, More Progress | Saama - #1 in AI Clinical Analytics
- 03One Place for All Data | Saama - #1 in AI Clinical Analytics
- 04When Every Day Counts
- 05Transforming Content Operations for 2x Faster Time to Market
- 06Astellas: Breaking Access Barriers with Veeva Compliant Chat